Transurethral resection of the prostate (TUR-P) and associated risk of infective endocarditis

Emil Loldrup Fosbøl1,2, Anna Stahl3, Andreas Røder4

  • 1The Heart Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. emil.fosboel@regionh.dk.

Infection
|December 20, 2024
PubMed
Abstract

Insights

Transurethral resection of the prostate (TUR-P) surgery significantly increases the risk of infective endocarditis (IE) within six months. While the absolute risk remains low, this finding highlights the need for improved prophylactic strategies to prevent IE after TUR-P.

Area of Science:

  • Urology
  • Infectious Diseases
  • Cardiology

Background:

  • Bacteremia is a known surgical complication that can lead to infective endocarditis (IE).
  • Transurethral resection of the prostate (TUR-P) can cause bacteremia, but its specific risk for IE is not well-established.
  • Understanding the IE risk following TUR-P is crucial for patient management and preventative measures.

Purpose of the Study:

  • To investigate the risk of developing infective endocarditis (IE) after undergoing Transurethral resection of the prostate (TUR-P).
  • To compare the incidence of IE in patients who had TUR-P with an age-matched control group from the general population.

Main Methods:

  • A cohort study comparing 25,781 patients undergoing TUR-P between 2010 and 2020 with an age-matched control group.
  • Patients were monitored for IE development within 6 months and 6-12 months post-TUR-P.
  • Statistical analysis involved cumulative incidences and time-dependent Cox regression models.

Main Results:

  • The incidence of IE was significantly higher within 6 months after TUR-P compared to the background population (adjusted HR 8.16).
  • Enterococcus faecalis was the most common pathogen identified in IE cases (72.7%).
  • The elevated risk for IE diminished between 6-12 months post-TUR-P (adjusted HR 2.15).

Conclusions:

  • Transurethral resection of the prostate (TUR-P) is associated with an eight-fold increased risk of infective endocarditis (IE) within 6 months post-surgery.
  • Despite the low absolute risk, TUR-P is a significant risk factor for IE.
  • Further research into enhanced prophylactic interventions for IE following TUR-P is warranted.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...